Clinical Outcomes and Patients’ Satisfaction of a New Trifocal Toric Intraocular Lens | ASCRS
Clinical Outcomes and Patients’ Satisfaction of a New Trifocal Toric Intraocular Lens
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-102 Toric IOLs - Astigmatism
Author: Yonca Aydin Akova
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

To evaluate the clinical outcomes and quality of life following femtosecond laser assisted cataract surgery (FLACS) and implantation of PanOptix trifocal toric intraocular lens (IOL).

This prospective, non comparative, non-randomized study included 30 eyes of 23 patients with ≥1 D with the rule or ≥0.75 D against the rule astigmatism who underwent FLACS with the implantation of PanOptix trifocal toric IOL between April 2018-June 2019 at Bayindir Hospital. Corneal astigmatism (CA), refractive astigmatism (RA), uncorrected visual acuity for distance, intermediate and near (UDVA, UIVA, UNVA), defocus curves, presence of dysphotopsia and posterior capsule opacification (PCO), need for spectacles, photopic and mesopic contrast sensitivity (MCS), rotational stability, visual function-14 (VF-14) tests were evaluated at postoperative (po) 3rd months.

The mean UDVA, UIVA and UNVA were 0.01±0.05, 0.06±0.07 and 0.07±0.07 logMAR, respectively. Six eyes received T2 toric model, whereas 12 eyes T3, 5 eyes T4, 3 eyes T5 and 4 eyes T6 were implanted. All patients reached ≥0.3 logmar uncorrected visual acuity for all distances. The mean CA was 1.6±0.8 (0-4.75) D. The mean RA decreased from 1.8±1.2 (0-4.75) D to 0.41±0.3 (0-1) D. All eyes had ≤1 D of subjective RA postoperatively. Defocus curve had two peaks at 0 and -1.50 D. Spectacle independence was achieved in % patients (28 eyes). The mean VF-14 score was 97.6±2. The mean IOL axis rotation was 2.8±3.400. Three patients reported seeing nondisturbing halos. One patient had PCO. 

This trifocal toric IOL effectively reduced refractive astgimatism and provided excellent visual outcomes with high spectacle independence, patients’ satisfaction and good rotational stability.
View More Presentations from this Session

This presentation is from the session "SPS-102 Toric IOLs - Astigmatism" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.